Potential for targeting aggressive breast cancers shown by new UK study

[News]

A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.

More... (http://www.medicalnewstoday.com/releases/272544.php)